Debating the Evidence of Pharmacogenetic Testing

Pat Deverka, MD, MS participated in a 6 member debate entitled “DEBATING ABOUT THE EVIDENCE FOR CLINICAL UTILITY OF PHARMACOGENETIC TESTING” at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2014 Annual Meeting in Atlanta, GA.

Pat's presentation focused on the importance of  enabling higher evidence standards (RCT’s), and proposed that clinical utility studies should be designed to answer real-world decisions. (Download the full presentation on the right.)